LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.550
-0.020 (-1.27%)
At close: Sep 8, 2025, 4:00 PM
1.550
0.00 (0.00%)
After-hours: Sep 8, 2025, 4:00 PM EDT

LAVA Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
4.9911.986.7719.395.353.75
Upgrade
Revenue Growth (YoY)
-32.55%77.01%-65.09%262.45%42.78%-
Upgrade
Cost of Revenue
24.5524.5536.04--15.7
Upgrade
Gross Profit
-19.56-12.57-29.2719.395.35-11.95
Upgrade
Selling, General & Admin
11.7913.2314.1214.1212.022.72
Upgrade
Research & Development
-5.31--40.1136.95-
Upgrade
Operating Expenses
6.4813.2314.1254.2348.962.72
Upgrade
Operating Income
-26.04-25.79-43.39-34.84-43.61-14.67
Upgrade
Interest Expense
-0.39-0.52-0.47--0.63-0.34
Upgrade
Interest & Investment Income
3.143.763.670.26--
Upgrade
Currency Exchange Gain (Loss)
-2.371.97-1.422.922.04-0.87
Upgrade
EBT Excluding Unusual Items
-25.65-20.58-41.61-31.66-42.2-15.88
Upgrade
Merger & Restructuring Charges
-7.1-3.9----
Upgrade
Pretax Income
-27.55-24.48-41.61-31.66-42.2-15.88
Upgrade
Income Tax Expense
0.770.630.260.250.160.04
Upgrade
Net Income
-28.32-25.11-41.87-31.91-42.36-15.93
Upgrade
Net Income to Common
-28.32-25.11-41.87-31.91-42.36-15.93
Upgrade
Shares Outstanding (Basic)
27272726200
Upgrade
Shares Outstanding (Diluted)
27272726200
Upgrade
Shares Change (YoY)
-0.42%0.38%3.12%31.21%4850.36%-10.81%
Upgrade
EPS (Basic)
-1.05-0.94-1.57-1.23-2.14-39.90
Upgrade
EPS (Diluted)
-1.05-0.94-1.57-1.23-2.14-39.90
Upgrade
Free Cash Flow
-35.9-19.57-41.013.46-29.41-9.81
Upgrade
Free Cash Flow Per Share
-1.34-0.73-1.530.13-1.49-24.58
Upgrade
Gross Margin
--104.89%-100.00%100.00%-
Upgrade
Operating Margin
-521.84%-215.26%-641.07%-179.66%-815.20%-391.59%
Upgrade
Profit Margin
-567.62%-209.60%-618.57%-164.55%-791.68%-425.06%
Upgrade
Free Cash Flow Margin
-719.52%-163.30%-605.91%17.82%-549.74%-261.78%
Upgrade
EBITDA
-25.72-25.33-42.78-34.33-43.28-14.46
Upgrade
EBITDA Margin
--211.37%--177.06%--
Upgrade
D&A For EBITDA
0.320.470.610.50.330.21
Upgrade
EBIT
-26.04-25.79-43.39-34.84-43.61-14.67
Upgrade
EBIT Margin
--215.26%--179.66%--
Upgrade
Revenue as Reported
4.9911.986.77--3.75
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q